Search

everythinglearnresearchcommunity

for

Search:↓

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Skin health and repair depend on the signals between skin stem cells and their surrounding cells.

ATP-dependent chromatin-remodeling complexes are crucial for gene regulation, cell differentiation, and organ development in mammals.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

FoxN1 overexpression in young mice harms immune cell and skin development.

Cyclosporin A promotes hair cell growth and affects protein kinase C levels.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Alopecia areata involves immune response and gene changes affecting hair loss.

Non-immune factors play a significant role in alopecia areata.

miR-29 is a key factor that accelerates aging.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

FOXN1 gene variants cause low T cells and immune issues from birth.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Scientists successfully edited a goat's genes to grow more and longer cashmere hair.